Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)

Tools

Gao, Ya, Liu, M, Liu, L, Zhang, J, Song, F and Tian, J (2022) Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol). Cochrane Database of Systematic Reviews, 2022 (9). ISSN 1361-6137

[thumbnail of Gao_et_al-2022-Cochrane_Database_of_Systematic_Reviews]

Preview

PDF (Gao_et_al-2022-Cochrane_Database_of_Systematic_Reviews) - Published Version
Download (183kB) | Preview

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.

Item Type:	Article
Uncontrolled Keywords:	pharmacology (medical),sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2736
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Centres > Population Health
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	08 Nov 2022 17:30
Last Modified:	06 Apr 2024 01:25
URI:	https://ueaeprints.uea.ac.uk/id/eprint/89710
DOI:	10.1002/14651858.CD015072

Downloads

Downloads per month over past year

Actions (login required)

View Item